SHENZHEN, China, Dec. 27, 2010 /PRNewswire-Asia-FirstCall/ --
Mindray Medical International Limited (NYSE: MR), a leading
developer, manufacturer and marketer of medical devices worldwide,
today announced shareholder resolutions adopted at its annual
general meeting of shareholders held in Hong Kong on December
22, 2010.
At the meeting, Mindray shareholders approved the re-election of
incumbent directors Ms. Joyce I-Yin Hsu and Mr. Wu Qiyao, each to
serve a three-year term.
In addition, Mindray shareholders ratified the appointment of
PricewaterhouseCoopers as the company's independent registered
public accounting firm for the fiscal year ending December 31, 2010.
About Mindray
We are a leading developer, manufacturer and marketer of medical
devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in
Mahwah, New Jersey and multiple
sales offices in major international markets. From our main
manufacturing and engineering base in China and through our worldwide distribution
network, we are able to supply internationally a broad range of
products across three primary business segments, comprised of
patient monitoring and life support products, in-vitro diagnostic
products and medical imaging systems. For more information, please
visit http://www.mindray.com.
|
For investor and media
inquiries please contact:
|
|
|
|
|
In the U.S.:
|
|
|
Hoki Luk
Western Bridge,
LLC
Tel:
+1-646-808-9150
Email:
hoki.luk@westernbridgegroup.com
|
|
|
|
|
In China:
|
|
|
Cathy Gao
Mindray Medical
International Limited
Tel:
+86-755-2658-2620
Email:
cathy.gao@mindray.com
|
|
|
|
SOURCE Mindray Medical International Limited